|
Volumn 368, Issue 26, 2013, Pages 2522-2523
|
Combination antifungal therapy for cryptococcal meningitis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPHOTERICIN B;
FLUCONAZOLE;
FLUCYTOSINE;
CREATININE;
ELECTROLYTE;
COMBINATION CHEMOTHERAPY;
COMPARATIVE EFFECTIVENESS;
CRYPTOCOCCAL MENINGITIS;
DRUG APPROVAL;
DRUG COST;
DRUG INDICATION;
DRUG MANUFACTURE;
DRUG MARKETING;
HEALTH CARE ACCESS;
HEALTH CARE PLANNING;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LETTER;
MONOTHERAPY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
TREATMENT DURATION;
TREATMENT OUTCOME;
ANTIFUNGAL ACTIVITY;
BLOOD CELL COUNT;
CREATININE BLOOD LEVEL;
DRUG SAFETY;
ELECTROLYTE BLOOD LEVEL;
PATHOGEN CLEARANCE;
SURVIVAL RATE;
UNSPECIFIED SIDE EFFECT;
|
EID: 84879333609
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1305981 Document Type: Letter |
Times cited : (55)
|
References (5)
|